Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Japan newsletter		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	debapriya.paul@iqvia.com manually updating trust level from 1 to 0		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	debapriya.paul@iqvia.com manually updating trust level from 1 to 0		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	debapriya.paul@iqvia.com manually updating trust level from 1 to 0		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Mon, 07/27/2020 - 08:10	Opened		Anonym
Newsletter opened	Mon, 07/27/2020 - 08:10	Opened		Anonym
Newsletter opened	Mon, 07/27/2020 - 08:10	Opened		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Japan newsletter		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	debapriya.paul@iqvia.com manually updating trust level from 1 to 0		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	debapriya.paul@iqvia.com manually updating trust level from 1 to 0		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	debapriya.paul@iqvia.com manually updating trust level from 1 to 0		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Mon, 07/27/2020 - 08:10	Opened		Anonym
Newsletter opened	Mon, 07/27/2020 - 08:10	Opened		Anonym
Newsletter opened	Mon, 07/27/2020 - 08:10	Opened		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/en/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER